221 related articles for article (PubMed ID: 8729158)
41. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
[TBL] [Abstract][Full Text] [Related]
42. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
Saco M; Howe N; Nathoo R; Cherpelis B
Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
[TBL] [Abstract][Full Text] [Related]
43. The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study.
Kavros SJ; Dutra T; Gonzalez-Cruz R; Liden B; Marcus B; McGuire J; Nazario-Guirau L
Adv Skin Wound Care; 2014 Aug; 27(8):356-62. PubMed ID: 25033310
[TBL] [Abstract][Full Text] [Related]
44. A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers.
Niederauer MQ; Michalek JE; Armstrong DG
J Diabetes Sci Technol; 2017 Sep; 11(5):883-891. PubMed ID: 28654304
[TBL] [Abstract][Full Text] [Related]
45. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds.
Eginton MT; Brown KR; Seabrook GR; Towne JB; Cambria RA
Ann Vasc Surg; 2003 Nov; 17(6):645-9. PubMed ID: 14534844
[TBL] [Abstract][Full Text] [Related]
46. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
[TBL] [Abstract][Full Text] [Related]
47. Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing.
Yang C; Weng H; Chen L; Yang H; Luo G; Mai L; Jin G; Yan L
J Wound Ostomy Continence Nurs; 2013; 40(6):585-9. PubMed ID: 24202221
[TBL] [Abstract][Full Text] [Related]
48. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
49. Effect of noncontact normothermic wound therapy on the healing of neuropathic (diabetic) foot ulcers: an interim analysis of 20 patients.
Alvarez OM; Rogers RS; Booker JG; Patel M
J Foot Ankle Surg; 2003; 42(1):30-5. PubMed ID: 12567365
[TBL] [Abstract][Full Text] [Related]
50. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.
Lullove EJ
Wounds; 2017 Apr; 29(4):107-114. PubMed ID: 28448264
[TBL] [Abstract][Full Text] [Related]
51. Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study.
Yao M; Attalla K; Ren Y; French MA; Driver VR
J Am Podiatr Med Assoc; 2013; 103(4):274-80. PubMed ID: 23878379
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Efficacy of Highly Hydrophilic Polyurethane Foam Dressing in Treating a Diabetic Foot Ulcer.
Jung JA; Yoo KH; Han SK; Dhong ES; Kim WK
Adv Skin Wound Care; 2016 Dec; 29(12):546-555. PubMed ID: 27846028
[TBL] [Abstract][Full Text] [Related]
53. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.
Margolis DJ; Kantor J; Berlin JA
Diabetes Care; 1999 May; 22(5):692-5. PubMed ID: 10332667
[TBL] [Abstract][Full Text] [Related]
54. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
[TBL] [Abstract][Full Text] [Related]
55. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
Abdo RJ
J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
[TBL] [Abstract][Full Text] [Related]
56. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
Zelen CM; Serena TE; Snyder RJ
Int Wound J; 2014 Apr; 11(2):122-8. PubMed ID: 24618401
[TBL] [Abstract][Full Text] [Related]
57. Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix.
Fridman R; Rafat P; Van Gils CC; Horn D; Vayser D; Lambert JC
Wounds; 2020 Sep; 32(9):244-252. PubMed ID: 32813669
[TBL] [Abstract][Full Text] [Related]
58. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.
Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH
Wound Repair Regen; 2007; 15(1):23-34. PubMed ID: 17244316
[TBL] [Abstract][Full Text] [Related]
59. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group.
Steed DL; Ricotta JJ; Prendergast JJ; Kaplan RJ; Webster MW; McGill JB; Schwartz SL
Diabetes Care; 1995 Jan; 18(1):39-46. PubMed ID: 7698046
[TBL] [Abstract][Full Text] [Related]
60. Primary wound closure of diabetic foot ulcers by debridement and stitching.
Ahmed ME; Mohammed MS; Mahadi SI
J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
